Source: Zero Hedge Don’t call it a comeback, because even though he’s 16 months in to a seven-year federal prison sentence, Martin Shkreli has never stopped running Phoenixus – the re-branded iteration of Shkreli’s Turing Pharmaceuticals – at least not according to the Wall Street Journal. Wielding a contraband cellphone,…